ARE YOU LESS THAN 20 WEEKS PREGNANT AND TESTED POSITIVE FOR ANTI-RO/SSA ANTIBODIES IN A COMMERCIAL LABORATORY?

You may be eligible for a research study entitled "Surveillance and Treatment tO Prevent Fetal Atrioventricular Block Likely to Occur Quickly" (STOP BLOQ)

Learn More

THIS STUDY WILL LAST ABOUT 2 YEARS AND WILL INVOLVE ABOUT 10 VISITS.*

If eligible, you will be asked to participate in 3 steps:

Step 1

A screening step to evaluate the level of autoantibodies to Ro52 and Ro60 (proteins in your blood).

Step 2

This step occurs if you are found to have high levels of anti-Ro60 or Ro52 antibodies and involves weekly or biweekly echoes and listening to your baby’s heartbeat 3x/day. The listening to the heart is called Fetal Heart Rate Monitoring.

Step 3

A treatment step consisting of dexamethasone and IVIG if heart block develops.

If you would like to know more about the study, please contact one of our study coordinators, or find a participating center near you.

Contact a Study Coordinator

View Participating Centers

*The study is voluntary

STOP BLOQ:
Surveillance and Treatment to Prevent AV Block Likely to Occur Quickly

Participating Centers | About The Investigators

The University of Arizona | College of Medicine Tucson

Clinical trials.gov identifier NCT04474223. Funded by NICHD RO1HD100929. Study ID/NYU IRB S20-00363.

THIS STUDY WILL LAST ABOUT 2 YEARS AND WILL INVOLVE ABOUT 10 VISITS.*

STOP BLOQ: Surveillance and Treatment to Prevent AV Block Likely to Occur Quickly

STOP BLOQ:
Surveillance and Treatment to Prevent AV Block Likely to Occur Quickly